Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Hershey Co (HSY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Hershey Co — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Hershey Co trades at $162.5 (market cap $32.22B). The key difference: Hershey Co is far larger — about 6.8× Definium Therapeutics Inc. Common Shares's market cap, and Hershey Co pays a 3.62% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Hershey Co for 135 Days on average.
| DFTX | HSY | |
|---|---|---|
Market Cap | $4.71B | $32.22B |
Volume | 1,966,636 | 944,010 |
Sector | Health | Consumer Staples |
52-Week High | $48.45 | $236.28 |
52-Week Low | $10.68 | $157.61 |
Typical Hold Time | 0 Days | 135 Days |
Enterprise Value | $3.67B | $37.35B |
Dividend Yield | — | 3.62% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Hershey (HSY) trades at $162.54, up 1.08% with a bearish technical signal but strong fundamentals. The company has beaten earnings estimates for three consecutive quarters, maintains robust profitability with 12.24% net margin and 32.81% ROE, and offers a $1.45 dividend. Recent news highlights brand investments and international leadership changes. Current price sits near key support at $160 with resistance at $163.
HSY presents a mixed outlook with strong operational performance offset by technical weakness. The stock trades at a discount to analyst consensus target of $204.62, offering potential upside. Key risks include commodity cost pressures and competitive threats, while institutional sentiment remains cautious with 68.57% hold ratings. Earnings momentum and dividend stability support long-term value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Hershey Co
Hershey is a leading confectionery manufacturer in the U.S. (around a $25 billion market), controlling around 46% of the domestic chocolate space (per IRI). Beyond its namesake label, the firm's mix has expanded over the last 85 years and now consists of 100 brands, including Reese's, Kit Kat, Kisses, and Ice Breakers. Hershey's products are sold in about 80 countries, albeit with just a high-single-digit percentage of sales coming from markets outside the U.S., including Brazil, India, and Mexico. The firm has sought inorganic opportunities to extend its reach beyond its core confection business, adding Amplify Snack Brands and its Skinny Pop ready-to-eat popcorn to its mix and Pirate Brands (including the Pirate's Booty, Smart Puffs, and Original Tings brands) over the past few years.
Read more on HSY →
